Cingulate Inc.
NASDAQ:CINGBiotechnology
Healthcare
$5.11 -0.95%
-$0.05 today
- Market cap
- $76.46M
- Beta
- -0.91
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$5.10
52W Low $3.16High $11.89
Volume 0.95M
Average 0.46M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$19.94M
FY 2025 · Annual
Net Income
-$22.45M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 8.41M | 9M | 15.49M | 9.45M | 9.77M |
| Selling, General & Admin | 12.27M | 8.51M | 7.27M | 6.2M | 10.16M |
| Operating Expenses | 20.68M | 17.5M | 22.76M | 15.64M | 19.94M |
| Depreciation & Amortization | 708.32K | 394.01K | 582.92K | 653.09K | 540.89K |
| EBITDA | (19.97M) | (17.11M) | (22.18M) | (14.99M) | (19.4M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (20.68M) | (17.5M) | (22.76M) | (15.64M) | (19.94M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 175 | 775.76K | 0 | 369.27K |
| Interest Expense | 33.41K | 174K | 0 | 0 | 924.45K |
| Other Income / Expenses | (30.59K) | (174.51K) | (775.76K) | (914.63K) | (2.51M) |
| Income Before Tax | (20.71M) | (17.68M) | (23.53M) | (16.56M) | (22.45M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (20.71M) | (17.68M) | (23.53M) | (16.56M) | (22.45M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (55.80) | (31.20) | (311.99) | (10.20) | (4.13) |
| EPS (Diluted) | (55.80) | (31.20) | (311.99) | (10.20) | (4.13) |
| 1.41M | 1.41M | 2.26M | 3.81M | 5.43M | |
| 1.41M | 1.41M | 2.26M | 3.81M | 5.43M |
CING Earnings Waterfall · TTM
NASDAQ:CING · Revenue to Net Income
Key Ratios
EPS$-5.02
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.0
P/S Ratio0.0
Analysis
$0 of revenue converted into -$27.7M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-5.02, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 13, 2026 | |
| 424B3 | 424B3 filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 13, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 2, 2026 |
How much revenue does CING generate?
Cingulate Inc. (CING) reported $0.00 of revenue in fiscal 2025.
Is CING profitable?
Cingulate Inc. (CING) reported -$22.45M of net income.
Continue the stock analysis
Jump to another research area for this company.